Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy [Phase 2]
Phase 2 study of abiraterone acetate in chemo-naive metastatic castration-resistant prostate cancer patients with prior diethylstilbestrol e…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 1, Phase 2]
Clinical trial update on radiation therapy for stage II/III prostate cancer (Phase 1/2) completed.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy [NA]
Clinical trial update assessing how catheter size affects peri-operative pain after robotic-assisted laparoscopic prostatectomy.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer [Phase 1]
Phase 1 trial of a multi-target recombinant vaccine targeting CEA/MUC1/Brachyury in advanced cancer completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Prostate Cancer Survivors and Exercise and Behavioral Counseling [Phase 2]
A Phase 2 clinical trial update evaluating exercise and behavioral counseling for prostate cancer survivors, completed, with outcomes likely…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 study update evaluating safety and pharmacokinetics of ODM-204 in metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: FACBC Prostate Therapy Response [Phase 2]
Phase 2 clinical trial update for FACBC prostate therapy in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer [Phase 3]
Expanded access trial update for diagnostic imaging in staging recurrent metastatic prostate cancer; Phase 3 completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Doxercalciferol Before Surgery in Treating Localized Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating doxercalciferol before surgery in localized prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 clinical trial update for perillyl alcohol in metastatic prostate cancer after hormone therapy failure. Status: COMPLETED.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Effect of Cancer Nurse Navigators on Patient Outcomes [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the impact of cancer nurse navigators on patient outcomes has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide [Phase 2]
A Phase 2 trial evaluating abiraterone acetate plus LHRH agonist, and abiraterone acetate plus LHRH agonist with enzalutamide, in prostate c…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer [Phase 2]
Phase 2 trial evaluating bicalutamide with or without the Akt inhibitor MK-2206 in previously treated prostate cancer has posted results. Th…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy [Phase 2]
Phase 2 clinical trial investigating vitamin D in men undergoing prostatectomy for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence [Phase 2, Phase 3]
Clinical trial update on Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Cardiovascular Events in GnRH Agonist vs. Antagonist [Phase 2]
Phase 2 trial update comparing GnRH agonist vs antagonist with a focus on cardiovascular events in prostate cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning [NA]
Clinical trial update on incorporating MR imaging into prostate radiotherapy treatment planning; trial completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a [NA]
Clinical trial update on genomic-targeted chemoprevention for prostate cancer, completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer [Phase 3]
Phase 3 trial evaluating a subcutaneous four-month sustained-release formulation of triptorelin in prostate cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial update for ABI-008 in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC) [Phase 2]
Phase 2 trial update evaluating intermittent chemotherapy with or without GM-CSF in metastatic hormone-refractory prostate cancer; results p…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Therapeutics in Active Prostate Cancer Surveillance [Phase 2]
Phase 2 clinical trial update for therapeutics in active prostate cancer surveillance has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: A Research Study for Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update for patients with prostate cancer, including metastatic cases, completed.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating natural dendritic cells for immunotherapy in chemo-naive metastatic castration-resistant prostate cancer has comple…
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update for Lutetium-177-PSMA-617 in low-volume metastatic prostate cancer completed.